What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2023-05-15 compared with 2022-11-07 · 25 added, 38 removed, 10 unchanged (86% of the section changed)

Other Information

and Restated Certificate of Incorporation, as amended through September 30, 2015 (incorporated by reference to Exhibit 3.1 to Quarterly

Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2015)

and Restated Bylaws (incorporated by reference to Exhibit 3.2 to Current Report on Form 8-K filed with the Securities and Exchange

Commission on June 29, 2021)

of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc.

(incorporated by reference to Exhibit 3.1 to

the Current Report on Form 8-K filed on May 25, 2016)

of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc.

(incorporated by reference to Exhibit 3.1 to

the Current Report on Form 8-K filed on September 29, 2016)

of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock (incorporated by reference to Exhibit

3.1 to the Current Report on Form 8-K filed on March 15, 2017)

of Amendment to Certificate of Designation of Preferences, Rights and Limitation of Series C Convertible Preferred Stock (incorporated

by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on November 29, 2017)

of Amendment to Certificate of Designation of Preferences, Rights and Limitation of Series B Convertible Preferred Stock (incorporated

by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on December 12, 2017)

of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc.

(incorporated by reference to Exhibit 3.1 to

the Current Report on Form 8-K filed on February 7, 2018)

of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc.

(incorporated by reference to Exhibit 3.1 to

the Current Report on Form 8-K filed on March 28, 2019)

of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc., dated April 14, 2021 (incorporated by reference

to Exhibit 3.17 to the Quarterly Report on Form 10-Q filed on May 10, 2021)

Certification

of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification

of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification

of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Certification

of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in inline

XBRL (eXtensible Business Reporting Language), (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements

of Operations, (iii) Condensed Consolidated Statements of Cash Flows, and (v) the Notes to the Condensed Consolidated Financial Statements

Amended and Restated Certificate of Incorporation, as amended through March 31, 2015 (incorporated by reference to Exhibit 3.1 to Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2015)

Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to Current Report on Form 8-K filed with the Securities and Exchange Commission on June 29, 2021)

Certificate of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc.

(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on May 25, 2016)

Certificate of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc.

(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on September 29, 2016)

Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on March 15, 2017)

Certificate of Amendment to Certificate of Designation of Preferences, Rights and Limitation of Series C Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on November 29, 2017)

Certificate of Amendment to Certificate of Designation of Preferences, Rights and Limitation of Series B Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on December 12, 2017)

Certificate of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc.

(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on February 7, 2018)

Certificate of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc.

(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on March 28, 2019)

Certificate of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc., dated April 14, 2021 (incorporated by reference to Exhibit 3.17 to the Quarterly Report on Form 10-Q filed on May 10, 2021)

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

XBRL Instance Document (the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within

the Inline XBRL document)

XBRL Taxonomy Extension Schema Document

XBRL Taxonomy Extension Calculation Linkbase Document

XBRL Taxonomy Extension Definition Linkbase Document

XBRL Taxonomy Extension Labels Linkbase Document

XBRL Taxonomy Extension Presentation Linkbase Document

Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

Filed herewith.

Management contract or compensatory plan or arrangement.

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned thereunto duly authorized.

November 7, 2022

Marvin Slosman

1 unchanged sentence

Executive Officer)

November 7, 2022

Financial Officer, Secretary and Treasurer

1 unchanged sentence

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information